UBS AG - Listing of UBS Autocallable Note linked to Adyen N.V. shares due 2029 Series 23

Listing of UBS Autocallable Note linked to Adyen N.V. shares due 2029 – Series 23

UBS AG, London Branch
("UBS AG" or the "Company")
(Incorporated and domiciled in Switzerland)
(Registration number: CHE-101.329.561)

Listing of UBS Autocallable Note linked to Adyen N.V. shares due 2029 –
Series 23.

The JSE Limited has granted UBS approval for the listing of the Autocallable
Note linked to Adyen N.V. (Bloomberg: ADYEN NA Equity), due 19 February 2029.

This listing is issued under the Information Memorandum of UBS AG.

Trading will commence on Friday, 12 September 2025.

INSTRUMENT NUMBER:                     123174
ALPHA CODE:                            UAADY2
ISIN:                                  ZAE000352290
ISSUE SIZE (UNITS):                    200,000 (unit quotation)
ISSUE PRICE (RAND):                    1,000 per Note
COUPON RATE:                           13.0900%

UNDERLYING STOCKS:                     Adyen N.V.
                                       (Bloomberg: ADYEN NA Equity)

LISTING DATE:                          Friday, 12 September 2025
EXPIRY DATE:                           Monday, 19 February 2029
EXPIRY OBSERVATION DATE:               Monday, 19 February 2029
FINALISATON ANNOUNCEMENT BY 08:00AM:   Tuesday, 20 February 2029
LAST DATE TO TRADE:                    Tuesday, 20 February 2029
SUSPENSION DATE:                       Wednesday, 21 February 2029
RECORD DATE:                           Friday, 23 February 2029
PAYMENT DATE:                          Tuesday, 27 February 2029
TERMINATION DATE:                      Wednesday, 28, February 2029

For further information kindly contact:

UBS KeyInvest South Africa
Tel.: +27 11 322 7129 / 7317
E-mail: keyinvestza@ubs.com
Web: http://keyinvest-za.ubs.com/products

Johannesburg
11 September 2025

Sponsor: UBS South Africa (Pty) Limited

Date: 11-09-2025 04:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.